Literature DB >> 28369700

In utero presentation of aggressive systemic mastocytosis in a neonate.

A Huang1, N Fiadorchanka1, K Brar2, J L Balderacchi3, S A Glick1.   

Abstract

Mastocytosis is a clinically heterogenous disease characterized by mast cell hyperplasia in skin, bone marrow and/or visceral organs. Cutaneous mastocytosis is more frequently observed in children, whereas indolent systemic mastocytosis is more commonly observed in adults. Aggressive systemic presentation, particularly of the neonate, is exceptionally rare. We present a rare case of congenital aggressive systemic mastocytosis. The patient was a 37-week-old male, born by caesarean section owing to hepatosplenomegaly and ascites diagnosed in utero, who exhibited extensive cutaneous and systemic manifestations of mastocytosis at birth. Mutation analysis of c-KIT identified D816V mutation in exon 17. Although initial bilateral bone marrow aspirates demonstrated no mast-cell infiltrates or haematological neoplasm, subsequent bone-marrow biopsies postmortem exhibited multifocal mast-cell aggregates. Clinical course was complicated by bacteraemia and cardiorespiratory failure, leading to death at 10 weeks.
© 2017 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2017        PMID: 28369700     DOI: 10.1111/bjd.15506

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

Review 1.  Mastocytosis in Children.

Authors:  Nicholas Klaiber; Santhosh Kumar; Anne-Marie Irani
Journal:  Curr Allergy Asthma Rep       Date:  2017-10-07       Impact factor: 4.806

Review 2.  Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021.

Authors:  Magdalena Lange; Karin Hartmann; Melody C Carter; Frank Siebenhaar; Ivan Alvarez-Twose; Inés Torrado; Knut Brockow; Joanna Renke; Ninela Irga-Jaworska; Katarzyna Plata-Nazar; Hanna Ługowska-Umer; Justyna Czarny; Anna Belloni Fortina; Francesca Caroppo; Roman J Nowicki; Bogusław Nedoszytko; Marek Niedoszytko; Peter Valent
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.